Investors in Biogen Inc (Symbol: BIIB) saw new options begin trading today, for the March 2026 expiration. One of the key data points that goes into the price an option buyer is willing to pay ...

Biogen Inc. announced that the FDA has accepted and the EMA has validated its supplemental New Drug Application for a higher dose regimen of nusinersen, intended for treating spinal muscular ...

Jane Grogan, Ph.D., took over Biogen’s research department in the wake of large-scale layoffs. Now, a little more than a year later, she’s making cuts of her own. The neuro-focused biotech is ...

To streamline the project and create an integrated Metro hub at JBS, Telangana Chief Minister A Revanth Reddy suggested that HAML explore the option of combining the Paradise-Medchal and JBS-Shamirpet ...

Sage Therapeutics has brought a lawsuit against Biogen shortly after receiving an “unsolicited” offer from its neuroscience partner. The lawsuit is sealed in Delaware’s Court of Chancery ...

GREELEY — Greeley-based JBS USA Food Co. has reached a $4 million settlement with the U.S. Department of Labor over for child-labor violations. The Jan. 13, 2025, agreement requires JBS to hold its ...

Sage Therapeutics last week sued partner Biogen just days after receiving an unsolicited buyout offer from the pharma for nearly $470 million, according to reporting by Bloomberg Law. The suit, filed ...

Hyderabad Airport Metro Rail (HAML) has decided to build a new JBS metro station towards the left of the existing JBS metro terminal station from where it proposes to combine metro rail extension ...

One thing you may notice on one of Sawyer's armbands is the saying "JBS Strong," which he's worn for several games during the Buckeyes' 2024-25 season. Let's take a look at why the Buckeyes' star ...

The agreement with JBS USA, based in Greeley, Colorado, follows a 2022 probe that found the company’s cleaning contractor employed dozens of children at its facilities, according to the Labor ...

Sage Therapeutics (NASDAQ:SAGE) is reportedly suing Biogen (NASDAQ:BIIB) over enforcement of a standstill agreement in the wake of an unsolicited takeover bid valued at around $469M. The full ...